Thursday - January 29, 2026

Category Archives: Business

Government Agencies and Enterprise Organizations Gain Streamlined Access to Mission-Ready Drone Systems Through Outland Secure

The gap between consumer drone retail and institutional procurement requirements creates real obstacles for agencies and enterprises trying to deploy aerial technology. We built Outland Secure specifically to bridge that gap with a procurement model that speaks the language of … Continue reading →

Donanemab by Eli Lilly and Company expected to drive market size of Alzheimer’s Disease

Explore the comprehensive Donanemab market report by a leading healthcare research firm, offering detailed insights, sales forecasts, and market analysis up to 2034.   [Las Vegas, United States] DelveInsight, a leader in healthcare research firm, has recently published an in-depth … Continue reading →

Spinal Cord Injury Market: Growth Momentum Across 7MM to 2034 – DelveInsight | Kringle Pharma, Neuroplast, Abbvie, Mitsubishi Tanabe Pharma, Lineage Cell Therapeutics, NervGen Pharma

The Key Spinal Cord Injury Companies in the market include – Athersys, Olatec Therapeutics, AlaMab therapeutics, ReNetX Bio, Histocell, Lineage Cell Therapeutics, AbbVie, Mitsubishi Tanabe Pharma, Pharmazz, Eusol Biotech, Kringle Pharma, NervGen Pharma, StemCyte, Inc., and others.   DelveInsight’s “Spinal … Continue reading →

Follicular Lymphoma Clinical Trial Pipeline Accelerates as 45+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s, “Follicular Lymphoma Pipeline Insight, 2025” report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Follicular Lymphoma pipeline landscape. It covers the Follicular Lymphoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →

Fabry Disease Clinical Trial Pipeline Gains Momentum: 18+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight

DelveInsight’s “Fabry Disease Pipeline Insight 2025” report provides comprehensive insights about 18+ companies and 18+ pipeline drugs in the Fabry Disease pipeline landscape. It covers the Fabry Disease pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →

Artificial Intelligence in Drug Commercialization: Market Projected to Grow at 24.12% CAGR Through 2032 | DelveInsight

Artificial Intelligence (AI) in Drug Commercialization DelveInsight Business Research, a leading pharmaceutical market research and business consulting firm, has released its latest market intelligence report on AI in Drug Commercialization. The report profiles leading companies, including EVERSANA, Lyfegen, Syneos Health, … Continue reading →

Chaynes Coffee Company Empowers E-Commerce Entrepreneurs with Premium Beverage Solutions and Risk-Free Sampling

“We understand the challenges facing online retailers who need to curate exceptional product selections while managing inventory risk. Our sampling program specifically addresses this need by allowing business owners to personally evaluate our blends before committing to stock, ensuring they … Continue reading →